These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 25151968)

  • 61. Critical and reciprocal regulation of KLF4 and SLUG in transforming growth factor β-initiated prostate cancer epithelial-mesenchymal transition.
    Liu YN; Abou-Kheir W; Yin JJ; Fang L; Hynes P; Casey O; Hu D; Wan Y; Seng V; Sheppard-Tillman H; Martin P; Kelly K
    Mol Cell Biol; 2012 Mar; 32(5):941-53. PubMed ID: 22203039
    [TBL] [Abstract][Full Text] [Related]  

  • 62. ROCK cooperated with ET-1 to induce epithelial to mesenchymal transition through SLUG in human ovarian cancer cells.
    Peng J; Zhang G; Wang Q; Huang J; Ma H; Zhong Y; Zhou F; Xie C; Zhang A
    Biosci Biotechnol Biochem; 2012; 76(1):42-7. PubMed ID: 22232246
    [TBL] [Abstract][Full Text] [Related]  

  • 63. YAP1 contributes to NSCLC invasion and migration by promoting Slug transcription via the transcription co-factor TEAD.
    Yu M; Chen Y; Li X; Yang R; Zhang L; Huangfu L; Zheng N; Zhao X; Lv L; Hong Y; Liang H; Shan H
    Cell Death Dis; 2018 May; 9(5):464. PubMed ID: 29700328
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hypoxia-inducible factor 1 alpha mediates epidermal growth factor-induced down-regulation of E-cadherin expression and cell invasion in human ovarian cancer cells.
    Cheng JC; Klausen C; Leung PC
    Cancer Lett; 2013 Feb; 329(2):197-206. PubMed ID: 23142284
    [TBL] [Abstract][Full Text] [Related]  

  • 65. FOXM1 promotes the epithelial to mesenchymal transition by stimulating the transcription of Slug in human breast cancer.
    Yang C; Chen H; Tan G; Gao W; Cheng L; Jiang X; Yu L; Tan Y
    Cancer Lett; 2013 Oct; 340(1):104-12. PubMed ID: 23856032
    [TBL] [Abstract][Full Text] [Related]  

  • 66. PTEN inactivation induces epithelial-mesenchymal transition and metastasis by intranuclear translocation of β-catenin and snail/slug in non-small cell lung carcinoma cells.
    Perumal E; So Youn K; Sun S; Seung-Hyun J; Suji M; Jieying L; Yeun-Jun C
    Lung Cancer; 2019 Apr; 130():25-34. PubMed ID: 30885348
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MicroRNA-150-5p promotes cell motility by inhibiting c-Myb-mediated Slug suppression and is a prognostic biomarker for recurrent ovarian cancer.
    Tung CH; Kuo LW; Huang MF; Wu YY; Tsai YT; Wu JE; Hsu KF; Chen YL; Hong TM
    Oncogene; 2020 Jan; 39(4):862-876. PubMed ID: 31570789
    [TBL] [Abstract][Full Text] [Related]  

  • 68. GSK3β controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of Slug.
    Kao SH; Wang WL; Chen CY; Chang YL; Wu YY; Wang YT; Wang SP; Nesvizhskii AI; Chen YJ; Hong TM; Yang PC
    Oncogene; 2014 Jun; 33(24):3172-82. PubMed ID: 23851495
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Stress effects on FosB- and interleukin-8 (IL8)-driven ovarian cancer growth and metastasis.
    Shahzad MM; Arevalo JM; Armaiz-Pena GN; Lu C; Stone RL; Moreno-Smith M; Nishimura M; Lee JW; Jennings NB; Bottsford-Miller J; Vivas-Mejia P; Lutgendorf SK; Lopez-Berestein G; Bar-Eli M; Cole SW; Sood AK
    J Biol Chem; 2010 Nov; 285(46):35462-70. PubMed ID: 20826776
    [TBL] [Abstract][Full Text] [Related]  

  • 70. LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression.
    Liang H; Yu T; Han Y; Jiang H; Wang C; You T; Zhao X; Shan H; Yang R; Yang L; Shan H; Gu Y
    Mol Cancer; 2018 Aug; 17(1):119. PubMed ID: 30098599
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Activation of NF-κB by TOPK upregulates Snail/Slug expression in TGF-β1 signaling to induce epithelial-mesenchymal transition and invasion of breast cancer cells.
    Lee YJ; Park JH; Oh SM
    Biochem Biophys Res Commun; 2020 Sep; 530(1):122-129. PubMed ID: 32828273
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Involvement of transcription repressor Snail in the regulation of human telomerase reverse transcriptase (hTERT) by transforming growth factor-β.
    Yoo YS; Park S; Gwak J; Ju BG; Oh S
    Biochem Biophys Res Commun; 2015 Sep; 465(1):131-6. PubMed ID: 26235880
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Long non-coding RNA linc00261 suppresses gastric cancer progression via promoting Slug degradation.
    Yu Y; Li L; Zheng Z; Chen S; Chen E; Hu Y
    J Cell Mol Med; 2017 May; 21(5):955-967. PubMed ID: 27878953
    [TBL] [Abstract][Full Text] [Related]  

  • 74. HOXB4 promotes the malignant progression of ovarian cancer via DHDDS.
    Li N; Gou JH; Xiong J; You JJ; Li ZY
    BMC Cancer; 2020 Mar; 20(1):222. PubMed ID: 32178630
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Snail and Slug, key regulators of TGF-β-induced EMT, are sufficient for the induction of single-cell invasion.
    Naber HP; Drabsch Y; Snaar-Jagalska BE; ten Dijke P; van Laar T
    Biochem Biophys Res Commun; 2013 May; 435(1):58-63. PubMed ID: 23618854
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Reduced expression of FILIP1L, a novel WNT pathway inhibitor, is associated with poor survival, progression and chemoresistance in ovarian cancer.
    Kwon M; Kim JH; Rybak Y; Luna A; Choi CH; Chung JY; Hewitt SM; Adem A; Tubridy E; Lin J; Libutti SK
    Oncotarget; 2016 Nov; 7(47):77052-77070. PubMed ID: 27776341
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ginsenoside 20(S)-Rg3 targets HIF-1α to block hypoxia-induced epithelial-mesenchymal transition in ovarian cancer cells.
    Liu T; Zhao L; Zhang Y; Chen W; Liu D; Hou H; Ding L; Li X
    PLoS One; 2014; 9(9):e103887. PubMed ID: 25197976
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Functional balance between Tcf21-Slug defines cellular plasticity and migratory modalities in high grade serous ovarian cancer cell lines.
    Varankar SS; More M; Abraham A; Pansare K; Kumar B; Narayanan NJ; Jolly MK; Mali AM; Bapat SA
    Carcinogenesis; 2020 Jun; 41(4):515-526. PubMed ID: 31241128
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Inhibition of human telomerase reverse transcriptase in vivo and in vitro for retroviral vector-based antisense oligonucleotide therapy in ovarian cancer.
    Qi Z; Mi R
    Cancer Gene Ther; 2016 Jan; 23(1):36-42. PubMed ID: 26742579
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors.
    Kyo S; Kanaya T; Takakura M; Tanaka M; Yamashita A; Inoue H; Inoue M
    Int J Cancer; 1999 Mar; 80(6):804-9. PubMed ID: 10074910
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.